These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 35982951)
1. Id2 exerts tumor suppressor properties in lung cancer through its effects on cancer cell invasion and migration. Chen JT; Hsu YL; Hsu YC; Tseng YH; Liu MH; Weng CW; Lin CH; Pan SH; Chen JJW; Wang CC Front Oncol; 2022; 12():801300. PubMed ID: 35982951 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of KCNJ4 correlates with cancer progression and unfavorable prognosis in lung adenocarcinoma. Wu XY; Yu XY J Biochem Mol Toxicol; 2019 Apr; 33(4):e22270. PubMed ID: 30512237 [TBL] [Abstract][Full Text] [Related]
3. Inhibitor of DNA-Binding Protein 4 Suppresses Cancer Metastasis through the Regulation of Epithelial Mesenchymal Transition in Lung Adenocarcinoma. Wang CC; Hsu YL; Chang CJ; Wang CJ; Hsiao TH; Pan SH Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31847356 [TBL] [Abstract][Full Text] [Related]
4. ID2 Inhibits Bladder Cancer Progression and Metastasis Mao W; Wang K; Sun S; Wu J; Chen M; Geng J; Luo M Front Cell Dev Biol; 2021; 9():738364. PubMed ID: 34746132 [No Abstract] [Full Text] [Related]
5. miR‑30a‑3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2. Wang H; Kanmangne D; Li R; Qian Z; Xia X; Wang X; Wang T Oncol Rep; 2020 Feb; 43(2):646-654. PubMed ID: 31894275 [TBL] [Abstract][Full Text] [Related]
6. miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4. Xiao X; Yang D; Gong X; Mo D; Pan S; Xu J Oncotarget; 2018 Feb; 9(15):11977-11988. PubMed ID: 29552286 [TBL] [Abstract][Full Text] [Related]
7. Effects of methylation and transcription factor YY1 on ID2 expression in non-small cell lung carcinoma cells. Tseng YH; Chou WR; Liu WL; Dung ZX; Lin CH; Hsieh CH; Wang CC Am J Cancer Res; 2024; 14(5):2424-2438. PubMed ID: 38859862 [TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the G protein-coupled receptor kinase 6 (GRK6) promoter inhibits binding of C/EBPα, and GRK6 knockdown promotes cell migration and invasion in lung adenocarcinoma cells. Yao S; Wu D; Chen J; Wang P; Lv X; Huang J FEBS Open Bio; 2019 Apr; 9(4):605-617. PubMed ID: 30984536 [TBL] [Abstract][Full Text] [Related]
9. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma. Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441 [No Abstract] [Full Text] [Related]
10. Prognostic value of decreased GRK6 expression in lung adenocarcinoma. Yao S; Zhong L; Liu J; Feng J; Bian T; Zhang Q; Chen J; Lv X; Chen J; Liu Y J Cancer Res Clin Oncol; 2016 Dec; 142(12):2541-2549. PubMed ID: 27601164 [TBL] [Abstract][Full Text] [Related]
11. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma. Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516 [TBL] [Abstract][Full Text] [Related]
13. Associations of Chang JH; Lai TC; Yang PJ; Shih PC; Yang YC; Lee KL; Liu TC; Tsao TC; Yang SF; Chien MH Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126605 [TBL] [Abstract][Full Text] [Related]
14. SH2B1 promotes epithelial-mesenchymal transition through the IRS1/β-catenin signaling axis in lung adenocarcinoma. Wang S; Cheng Y; Gao Y; He Z; Zhou W; Chang R; Peng Z; Zheng Y; Duan C; Zhang C Mol Carcinog; 2018 May; 57(5):640-652. PubMed ID: 29380446 [TBL] [Abstract][Full Text] [Related]
15. Inhibitor of DNA Binding 2 (ID2): A Novel Marker for Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma. Kim HR; Moon JH; Lee JH; Lim YC Ann Surg Oncol; 2021 Oct; 28(11):6479-6488. PubMed ID: 33783641 [TBL] [Abstract][Full Text] [Related]
16. p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma. Gu MM; Gao D; Yao PA; Yu L; Yang XD; Xing CG; Zhou J; Shang ZF; Li M Cancer Sci; 2018 Dec; 109(12):3783-3793. PubMed ID: 30281878 [TBL] [Abstract][Full Text] [Related]
17. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma. Zhang QH; Dai XH; Dai ZM; Cai YN Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853 [TBL] [Abstract][Full Text] [Related]
18. Wu G; Zhao Z; Yan Y; Zhou Y; Wei J; Chen X; Lin W; Ou C; Li J; Wang X; Xiong K; Zhou J; Xu Z Ann Transl Med; 2020 Mar; 8(6):341. PubMed ID: 32355785 [TBL] [Abstract][Full Text] [Related]
19. Roles of highly expressed PAICS in lung adenocarcinoma. Zhou S; Yan Y; Chen X; Wang X; Zeng S; Qian L; Wei J; Yang X; Zhou Y; Gong Z; Xu Z Gene; 2019 Apr; 692():1-8. PubMed ID: 30641222 [TBL] [Abstract][Full Text] [Related]
20. LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma. Zhou Y; Huan L; Wu Y; Bao C; Chen B; Wang L; Huang S; Liang L; He X Cancer Lett; 2020 Jan; 469():399-409. PubMed ID: 31730902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]